Literature DB >> 32819210

Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal.

Moussa Sarr1,2, Daouda Gueye2, Aminata Mboup2, Ousmane Diouf2, Mame D Bousso Bao2, Anna Julienne Ndiaye2, Birahim P Ndiaye2, Stephen E Hawes3, Eric Tousset4, Abdoulaye Diallo1, Fatima Jones1, Coumba T Kane2,5, Safiatou Thiam6, Cheikh T Ndour7, Geoffrey S Gottlieb8, Souleymane Mboup2.   

Abstract

The Senegal pre-exposure prophylaxis (PrEP) Demonstration Project was an open-label cohort study assessing the delivery of daily oral PrEP to HIV-negative female sex workers (FSWs) in four Ministry of Health (MoH)-run clinics in Dakar, Senegal. We assessed uptake, retention in care, and adherence over up to 12 months of follow-up as well as HIV infection rates. Between July and November 2015, 350 individuals were approached and 324 (92.6%) were preliminarily eligible. Uptake was high, with 82.4% of eligible participants choosing to enroll and take PrEP. The mean age of those enrolled was 37.7 years (SD = 8.7), and approximately half had not attended school (41.2%). Among the 267 participants who were prescribed PrEP, 79.9 and 73.4% were retained in PrEP care at 6 and 12 months, respectively. Older age among FSWs was found to be the only significant predictor of lower discontinuation. We did not find significant differences in retention by site, education, condom use, or HIV risk perception. There were no new HIV infections at follow-up. Our results showed evidence of high interest in PrEP and very good PrEP retention rates among FSWs at 12-month follow-up when offered in MoH-run clinics, with older age as the only significant predictor of higher PrEP retention. This highlights the role that these clinics can play in expanding PrEP access nationwide.

Entities:  

Keywords:  Africa; HIV; prevention; sex workers; women

Mesh:

Substances:

Year:  2020        PMID: 32819210      PMCID: PMC7750667          DOI: 10.1177/0956462420943704

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  27 in total

Review 1.  Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding.

Authors:  Lynne M Mofenson; Rachel C Baggaley; Ioannis Mameletzis
Journal:  AIDS       Date:  2017-01-14       Impact factor: 4.177

2.  Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.

Authors:  Catherine A Koss; Peter Bacchetti; Sharon L Hillier; Edward Livant; Howard Horng; Nyaradzo Mgodi; Brenda G Mirembe; Kailazarid Gomez Feliciano; Stephanie Horn; Albert Y Liu; David V Glidden; Robert M Grant; Leslie Z Benet; Alexander Louie; Ariane van der Straten; Z Mike Chirenje; Jeanne M Marrazzo; Monica Gandhi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-02       Impact factor: 2.205

3.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

4.  Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics.

Authors:  Hyman M Scott; Matthew Spinelli; Eric Vittinghoff; Alicia Morehead-Gee; Anne Hirozawa; Catherine James; Hali Hammer; Albert Liu; Monica Gandhi; Susan Buchbinder
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

5.  HIV prevalence, previous HIV testing, and condom use with clients and regular partners among Senegalese commercial sex workers.

Authors:  C Wang; S E Hawes; A Gaye; P S Sow; I Ndoye; L E Manhart; A Wald; C W Critchlow; N B Kiviat
Journal:  Sex Transm Infect       Date:  2007-10-17       Impact factor: 3.519

6.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321

Review 7.  Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.

Authors:  Jean B Nachega; Olalekan A Uthman; Lynne M Mofenson; Jean R Anderson; Steve Kanters; Francoise Renaud; Nathan Ford; Shaffiq Essajee; Meg C Doherty; Edward J Mills
Journal:  J Acquir Immune Defic Syndr       Date:  2017-09-01       Impact factor: 3.731

8.  HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.

Authors:  Robyn Eakle; Gabriela B Gomez; Niven Naicker; Rutendo Bothma; Judie Mbogua; Maria A Cabrera Escobar; Elaine Saayman; Michelle Moorhouse; W D Francois Venter; Helen Rees
Journal:  PLoS Med       Date:  2017-11-21       Impact factor: 11.069

9.  Changes Over Time in HIV Prevalence and Sexual Behaviour Among Young Female Sex-Workers in 14 Sites in Zimbabwe, 2013-2016.

Authors:  Sungai T Chabata; Bernadette Hensen; Tarisai Chiyaka; Phillis Mushati; Sibongile Mtetwa; Dagmar Hanisch; Sue Napierala; Joanna Busza; Sian Floyd; Elizabeth Fearon; Isolde Birdthistle; James R Hargreaves; Frances M Cowan
Journal:  AIDS Behav       Date:  2019-06

10.  Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up.

Authors:  Sushena Reza-Paul; Lisa Lazarus; Smarajit Jana; Protim Ray; Nelly Mugo; Kenneth Ngure; Morenike Oluwatoyin Folayan; Florita Durueke; John Idoko; Luc Béhanzin; Michel Alary; Daouda Gueye; Moussa Sarr; Wanjiru Mukoma; Jordan K Kyongo; Rutendo Bothma; Robyn Eakle; Gina Dallabetta; Josie Presley; Robert Lorway
Journal:  Gates Open Res       Date:  2019-07-05
View more
  7 in total

1.  Condom failure and pre-exposure prophylaxis use experience among female sex workers in Ethiopia: a qualitative study.

Authors:  Minilik Demissie Amogne; Eduard J Sanders; Wudinesh Belete Belihu; Jesper Sundewall; Anette Agardh
Journal:  BMC Public Health       Date:  2022-05-31       Impact factor: 4.135

2.  Qualitative Assessment of Barriers and Facilitators of PrEP Use Before and After Rollout of a PrEP Program for Priority Populations in South-central Uganda.

Authors:  William Ddaaki; Susanne Strömdahl; Ping Teresa Yeh; Anna Mia Ekström; Caitlin E Kennedy; Joseph G Rosen; Jade Jackson; Neema Nakyanjo; Joseph Kagaayi; Godfrey Kigozi; Gertrude Nakigozi; M Kathryn Grabowski; Larry W Chang; Steven J Reynolds; Fred Nalugoda
Journal:  AIDS Behav       Date:  2021-07-09

3.  Successful integration of HIV pre-exposure prophylaxis into a community-based HIV prevention program for female sex workers in Kolkata, India.

Authors:  Smarajit Jana; Protim Ray; Soma Roy; Abhijit Kadam; Raman R Gangakhedkar; B B Rewari; Stephen Moses; Marissa L Becker
Journal:  Int J STD AIDS       Date:  2021-02-18       Impact factor: 1.359

4.  PrEP acceptability and initiation among women engaged in sex work in Uganda: Implications for HIV prevention.

Authors:  Susan S Witte; Prema Filippone; Fred M Ssewamala; Proscovia Nabunya; Ozge Sensoy Bahar; Larissa Jennings Mayo-Wilson; Flavia Namuwonge; Christopher Damulira; Yesim Tozan; Joshua Kiyingi; Josephine Nabayinda; Abel Mwebembezi; Joseph Kagaayi; Mary McKay
Journal:  EClinicalMedicine       Date:  2022-01-28

5.  A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in Côte d'Ivoire: the ANRS 12381 PRINCESSE project.

Authors:  Valentine Becquet; Marcellin Nouaman; Serge Eholié; Joseph Larmarange; Mélanie Plazy; Aline Agoua; Clémence Zébago; Hervé Dao; Alice Montoyo; Aude Jary; Patrick A Coffie
Journal:  BMC Public Health       Date:  2021-12-04       Impact factor: 3.295

6.  Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study.

Authors:  Emilia M Jalil; Thiago S Torres; Paula M Luz; Laylla Monteiro; Ronaldo I Moreira; Cristiane R V de Castro; Iuri da C Leite; Marcello Cunha; Rita de Cássia Elias Estrela; Michelle Ramos; Brenda Hoagland; Sandra Wagner Cardoso; Peter Anderson; Valdilea G Veloso; Erin Wilson; Beatriz Grinsztejn
Journal:  J Int AIDS Soc       Date:  2022-03       Impact factor: 5.396

7.  HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program.

Authors:  Jackson Jr Nforbewing Ndenkeh; Anna L Bowring; Iliassou Mfochive Njindam; Romeo Dongfack Folem; Guy Christian Hendji Fako; Florent Gnintedem Ngueguim; Oscar Leyou Gayou; Kelly Lepawa; Christine Minka Minka; Christine Manyo Batoum; Sandra Georges; Edith Temgoua; Valery Nzima; David Anouar Kob; Zacheus Zeh Akiy; William Philbrick; Daniel Levitt; Dora Curry; Stefan Baral
Journal:  J Acquir Immune Defic Syndr       Date:  2022-05-10       Impact factor: 3.771

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.